Skip to main content

Table 1 Detailed classification of CAPA cases

From: Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

 

Aspergillus detected by mycological culture from BAL/NBL

Antigen detection

Radiological signs

Clinical signs

A. fumigatus

A. niger

A. flavus

A. nidulans

A. terreus

Ag Serum

Ag BAL/NBL

Pulmonary infiltrate

Cavitating infiltrate

Refractory fever

Pleural rub

Chest pain

Haemoptysis

Proven CAPA (n = 2)

100% (n = 2)

–

–

–

–

50% (n = 1)

50% (n = 1)

100% (n = 2)

–

50% (n = 1)

–

–

–

Probable CAPA (n = 29)

76% (n = 22)

10% (n = 3)

3% (n = 1)

3% (n = 1)

–

6% (n = 2)

66% (n = 19)

100% (n = 29)

6% (n = 2)

86% (n = 25)

–

3% (n = 1)

41% (n = 12)

Possible CAPA (n = 16)

81% (n = 13)

19% (n = 3)

–

–

–

–

–

100% (n = 16)

19% (n = 3)

69% (n = 11)

–

–

13% (n = 2)

Aspergillus spp. colonization (n = 18)

78% (n = 14)

–

–

–

6% (n = 1)

12% (n = 2)

24% (n = 4)

94% (n = 17)

6% (n = 1)

–

–

–

–

  1. A., aspergillus. CAPA, COVID-19-associated pulmonary aspergillosis. BAL, bronchoalveolar lavage. NBL, non-bronchoscopic lavage. Ag, antigen